Latest News

Robitussin Cough Syrup Recalled Nationwide Due to Fungus Concerns


 

Some Robitussin cough syrup products are being recalled nationwide due to potentially deadly microbial contamination.

The company that makes Robitussin syrups did not specify which microorganisms may be in the products. The recall announcement from the global consumer health products company Haleon stated that the contamination could lead to fungal infections or the presence of fungi or yeasts in a person’s blood. So far, the company has not received any reports of people being sickened by the recalled products.

The recall applies to bottles of Robitussin Honey CF Max Day and Robitussin Honey CF Max Nighttime. Both varieties are for adults. Affected products were sold nationwide and have specific lot numbers printed at the bottom of the back of the bottles. Consumers can view the lot numbers on the FDA’s recall webpage.

People with weakened immune systems have a higher risk of life-threatening health problems due to the cough syrup, the company warned.

“In non-immunocompromised consumers, the population most likely to use the product, life-threatening infections are not likely to occur,” the recall notice from Haleon stated. “However, the occurrence of an infection that may necessitate medical intervention cannot be completely ruled out.”

People who have affected products should stop using them immediately. The company asked that anyone with the products email Haleon at mystory.us@haleon.com, or call the company at 800-245-1040 Monday through Friday from 8 a.m. to 6 p.m. Eastern time.

A version of this article appeared on WebMD.com.

Recommended Reading

Nightmare on CIL Street: A Simulation Series to Increase Confidence and Skill in Responding to Clinical Emergencies
Federal Practitioner
Saltwater gargling may help avoid COVID hospitalization
Federal Practitioner
WHO: Smoking cessation reduces risk of type 2 diabetes up to 40%
Federal Practitioner
Intense exercise may lead to colds. A new study tells us why
Federal Practitioner
Discontinuation Schedule of Inhaled Corticosteroids in Patients With Chronic Obstructive Pulmonary Disease
Federal Practitioner
CPAP Oversells and Underperforms
Federal Practitioner
Invasive Procedures and Complications Follow Lung Cancer Screening
Federal Practitioner
How a Simple Urine Test Could Reveal Early-Stage Lung Cancer
Federal Practitioner
Will New Lung Cancer Screening Guidelines Save More Lives?
Federal Practitioner
A Military Nurse Saves a Life After a Brutal Rollover Crash
Federal Practitioner